The COA is not a marketing document. It's the release condition.
Three independent assays, one external lab, no exceptions. If a lot doesn't pass, it doesn't ship — and the synthesis batch is rejected.
Reverse-phase HPLC
C18 column, gradient elution, UV detection at 220 nm. Reported as area-percent purity against a reference standard. Release minimum: 99.0%. The chromatogram travels with every shipment.
ESI Mass Spectrometry
Electrospray ionisation MS in positive mode. Confirms molecular weight to within ±1 Da of the theoretical value. Detects truncations, byproducts and contamination invisible to HPLC alone.
LAL Endotoxin Assay
Limulus Amebocyte Lysate testing. Release ceiling: 0.5 EU/mg, well below the 5 EU/mg pharmacopoeial limit. Critical for any in-vitro work that touches a live cell line or primary culture.
What you do once the vial arrives.
Lyophilized peptides are surprisingly robust at ambient. Once reconstituted they are not. The same instructions ship with every order, and we'll restate them here.
Before reconstitution
Sealed lyophilized vials are stable for 24 months at −20 °C, 12 months at +4 °C and 4 weeks at room temperature in the dark. Shipping at ambient is fine.
Reconstitution
Bacteriostatic water (0.9% benzyl alcohol) for routine work; sterile saline or acetic acid (0.6%) for sensitive sequences. Inject solvent down the vial wall, swirl — don't shake.
After reconstitution
Use within 14–28 days at +4 °C depending on the sequence. For longer storage, aliquot and freeze at −80 °C — avoid freeze-thaw cycles, they degrade most peptides quickly.